Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research
Developing high-quality medicine is a resource-intense endeavor that requires collaboration across Novo Nordisk. Novo Nordisk aimed to scale a pipeline of drug discovery, development, and data science capabilities with AI and machine learning. In partnership with Microsoft Research, the teams built a Novo Nordisk AI platform on Azure AI and data stacks. Novo Nordisk amplified its culture of innovation by leveraging Microsoft Azure platform's AI capabilities across many use cases. The teams recently published initial results with predictive AI models for advanced risk detection in cardiovascular diseases, including an algorithm that can predict patients' cardiovascular risk better than the best clinical standards. Read this case study for lessons learned.
How is Novo Nordisk using AI in drug discovery?
Novo Nordisk is leveraging AI and machine learning to enhance its drug discovery and development processes. By building a Novo Nordisk AI platform on Microsoft Azure, the company is able to scale its capabilities and improve collaboration among life scientists, computational biologists, and data scientists. This platform supports various use cases, including predictive AI models for advanced risk detection in cardiovascular diseases.
What are the initial results of AI implementation at Novo Nordisk?
Novo Nordisk has reported promising initial results from its AI initiatives, particularly in cardiovascular disease risk detection. An algorithm developed through this effort can predict patients' cardiovascular risk more accurately than existing clinical standards. This demonstrates the potential of using AI to enhance precision medicine and improve treatment outcomes.
How does collaboration with Microsoft enhance Novo Nordisk's capabilities?
The collaboration between Novo Nordisk and Microsoft Research combines industry expertise in life sciences and applied AI, enabling the development of innovative solutions across various research areas. This partnership facilitates the creation of a unified AI platform that allows for better data discovery, reasoning, and model governance, ultimately supporting the company's goal of pioneering new medicines.
Transforming drug discovery: Novo Nordisk uses the power of AI and Azure with Microsoft Research
published by ITontology
In our cloud-first, mobile-first world, we are absolutely focused on empowering everyone within the organization. Hardware and software play a significant role in every company, but the primary focus has shifted to employees. Identity and conditional access are at the foundation of data protection, but collaboration is necessary in the Modern Workplace. Low level IT tasks are gone, and budgets have been refocused on securing and protecting data on every device from every location. Organizations that must meet certain compliance requirements have an extra layer of responsibility and accountability.
ITontology was founded to solve these challenges. In our cloud-first, mobile-first world the challenges can be overwhelming. Not to worry, our team and experience will guide you through the digital transformation process and empower everyone within your organization. Our vision, experience and powered 100% by Microsoft will provide best in class technology solutions. The best part, it’s all right at our fingertips and deployment can be automated from the cloud. The technology, security, value, and expense are finally all aligned. The time is now, and we are here to help, so let’s get to work on your digital transformation and turn your business into a Modern Workplace.
Sign in with LinkedIn